Farmigea S.p.A.
IT-MF-000018521 · Italy · Pisa
Farmigea S.p.A. is registered in the European database on medical devices as a manufacturer, with 42 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIb | 38 |
|---|---|
| Class IIa | 4 |
Most frequent device types declared: Carboxymethylcellulose 0.5% and 1% in single dose, multidose preservat, Dexpanthenol 5% gel, Hyaluronic acid 0.2% in multidose preservative free containers. Hyalur, Sodium Hyaluronate 0.4% multidose containers, Sodium Hyaluronate and TS-Polysaccharide in single dose and multidose .
Among these devices, 41 are declared sterile.
Devices declared under this manufacturer
- Aquoral
- Aquoral Forte
- Aquoral Forte 30 mini-containers
- BevitaEye Pro Hydra
- Bevitaeye Pro Hydra
- Cellusan
- Cellusan Light
- Evolve Carmellose
- HydraMed
- Hydramed
- Hye
- Intracinol
Showing 12 of 42 declared devices.
Catalogue references include 388, 389, 9000112, 9030379, 9030658-9031658, 9032308.
European nomenclature codes declared: Q02030206, Q02030201.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 42 |
| Country of registration | Italy |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 41 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Farmigea S.p.A. was not found in either the U.S. or the Canadian register.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
CSQ001123 | issued | 2028-06-13 |
57320 | supplemented | 2030-03-11 |
56318 | issued | 2028-11-27 |
56317 | issued | 2028-11-27 |
56317 | reissued | 2028-11-27 |